Cryopreserved Hair Follicles for Disease and Cell Replacement (Hair Follicles)
Characterization of Cryopreserved Plucked Hair Follicles and Generation of Functional Cell Lines for Disease Modeling and Cell Replacement Therapies
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Drew Taylor, MSc, PhD
- Phone Number: 226-929-8476
- Email: info@acorn.me
Study Locations
-
-
Quebec
-
Toronto, Quebec, Canada, M5R 0C7
- Recruiting
- Acorn Biolabs
-
Contact:
- Drew Taylor, MSc, PhD
- Phone Number: 226-929-8476
- Email: info@acorn.me
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Gender: Male or Female.
- Age: ≥18 and ≤80 years.
- Language proficiency: Able to read and understand English.
- Informed consent: Willing to provide written, informed consent to participate in all study activities.
Exclusion Criteria:
- Scalp/Hair Disorders: Subjects diagnosed with active scalp infections or inflammatory skin conditions.
- Systemic Conditions: Subjects with chronic illnesses, such as autoimmune diseases or diabetes, that may impact scalp health or wound healing.
- Medications: Subjects on immunosuppressants, steroids, or other medications associated with hair loss.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Hair Follicle Donors
Healthy individuals, aged 18-80, who will have hair follicles collected
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Characterize primary cellular outgrowth(s)
Time Frame: 30 days
|
10 hair follicles will be placed in a tissue culture plate per participants.
Over the course of 30 days, the outgrowth percentage (the number of outgrowths present out of 10 will be monitored and the confluency (percent of cells present in relation to surface area) will be noted for each participant.
|
30 days
|
|
Evaluate functional stem cell generation and induced pluripotent stem cell line(s) from primary outgrowth(s)
Time Frame: 21 days
|
1 million keratinocytes will be taken for reprogramming for each participant.
The number of iPS colonies observed on day 21 will be noted, resulting in a reprogramming efficiency score.
|
21 days
|
|
Evaluate and characterize differentiation of stem cell lines into functional cell types required for various disease states and cell-based application(s)
Time Frame: 30 days
|
iPS cell lines which have been confirmed to be pluripotent will be differentiated into pancreatic progenitor cells and hematopoietic stem cells.
The cells will be analyzed using FLOW cytometry and the percentage of double positive cells will be noted for each participant.
This will be repeated for multiple pathways such as the hematopoietic and endothelial lineage(s).
|
30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 24-003
- Company Sponsored (Other Identifier: Acorn Biolabs)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.